Focus on Alternative and Complementary Therapies
www.pharmpress.com/fact
Focus Alternat Complement Ther©2005 Pharmaceutical Press
Focus Altern Complement Ther 2004; 9: 241
US regulators have approved Barr Pharmaceuticals Inc’s second plant-derived female hormone replacement tablet, an alternative to animal-derived products, which have been linked to serious health risks. A Barr spokeswoman said that there is, however, no proof the company’s new tablets are safer than oestrogens made from animal proteins. The US Food and Drug Administration cleared the product for treatment of moderate to severe symptoms associated with menopause.
http://www.reutershealth.com/en/index.html, 11 May 2004
